The Asia Pacific stem cell therapy market, driven by rising demand for regenerative medicine and increased clinical trials.

The landscape of mental health care is shifting away from the rigid silos of the past. For decades, patients often had to choose between distinct modalities like clinical talk therapy, pharmaceutical ...

Centene Corporation posted a $1.1 billion loss in the fourth quarter of 2025 as it works to find ways to adapt to the ...

Rural and peri-urban healthcare settings in South Africa face enduring gaps in clinical capacity, infrastructure, and ...

The global preclinical imaging market is experiencing significant growth, propelled by increased R&D spending, adoption of ...

As nursing home operators seek wraparound services to help with staff burnout, turnover and retention, leaders in the sector ...

Psychiatrists, psychologists and psychotherapists may work with similar problems but they do in vastly different ways ...

Q4 2025 Earnings Call February 6, 2026 9:00 AM ESTCompany ParticipantsJennifer Gilligan - Senior Vice President of ...

The future of acne treatment might look a whole lot different than the range of oral and topical medications currently on ...

From 28 April, IVDs used clinical trials will be subject to an upfront assessment by the MHRA as part of a Clinical Trial of ...

Researchers at Moffitt Cancer Center have developed a new tool to predict how cancer cells evolve. By focusing on chromosome ...

The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...